• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE PROPATEN VASCULAR GRAFT; PROSTHESIS, VASCULAR GRAFT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE PROPATEN VASCULAR GRAFT; PROSTHESIS, VASCULAR GRAFT Back to Search Results
Catalog Number HT087080
Device Problem Fracture (1260)
Patient Problem Blood Loss (2597)
Event Date 12/05/2019
Event Type  Injury  
Event Description
On (b)(6) 2019, a patient underwent an axillary to bifemoral artery bypass procedure.On (b)(6) 2019 a reintervention took place using a gore propaten vascular graft.During the reintervention there was bleeding noted midgraft after tunnelling with an atrium tunneller.This required the use of pledgets for patching.Mild traction was placed on the graft during the procedure and this resulted in the graft fracturing and separating from the axillary end.A 6 mm atrium tunneller was passed through the graft but it perforated the graft at the groin end.The entire graft was explanted.The status of the patient is unknown currently.
 
Manufacturer Narrative
H.6.Results code 2: 213: a review of the manufacturing records verified the lot met all pre-release specifications.H.6.Results code 2: 213: the engineering evaluation stated the following: the device fragment was returned to w.L.Gore & associates for investigation.Submitted in formalin was a segment of a gore® propaten® vascular graft (stretch removable ring).The abluminal and luminal surfaces of the graft were largely devoid of tissue.No histopathological examination was performed.The graft was examined for material disruptions with the aid of a stereomicroscope.The returned segment exhibited a propaten® blue line pattern, had an inner diameter of approximately 8mm, and had a relaxed length of approximately 35cm.Mild yellow/brown staining was observed throughout the abluminal surface, and the segment was covered in mostly adhered rings.Neither end appeared cleanly cut.The ¿axillary¿ end exhibited a number of evenly spaced serrations, consistent with marks from a surgical instrument; some disrupted radial film was observed within the marks.A large hole was present about 2cm from the ¿groin¿ end of the segment.Two pledgets were sutured to the outer diameter approximately half-way down the returned segment.Removing the pledgets revealed multiple full thickness perforations and fep ring damage consistent with damage from a surgical instrument.The pledgets appeared to be cut-up pieces of a gore® propaten® vascular graft.The identity of the returned device matches the device described in the event.The condition of the returned device is consistent with the event description.The examination found no anomalies attributable to the manufacture of the device.
 
Manufacturer Narrative
D.6.Updated.
 
Manufacturer Narrative
Implant/ explant date updated.
 
Manufacturer Narrative
Updated.Updated.Confirmed.
 
Event Description
The following information was reported to gore: on (b)(6) 2019 a patient underwent an axillary-femoral or axillary bi-femoral bypass procedure with a using a gore® propaten® vascular graft.On (b)(6) 2019 a reintervention took place, possibly due to bleeding.During the reintervention there was bleeding noted midgraft after tunnelling with an atrium tunneller.This required the use of pledgets for patching.Mild traction was placed on the graft during the procedure and this resulted in the graft fracturing and separating from the axillary end.A 6mm atrium tunneller was passed through the graft but it perforated the graft at the groin end.The entire graft was explanted.The patient outcome is unknown.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE PROPATEN VASCULAR GRAFT
Type of Device
PROSTHESIS, VASCULAR GRAFT
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
MDR Report Key9587017
MDR Text Key174902975
Report Number2017233-2020-00031
Device Sequence Number1
Product Code DSY
Combination Product (y/n)N
PMA/PMN Number
K062161
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Type of Report Initial,Followup,Followup,Followup,Followup
Report Date 03/30/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date07/13/2023
Device Catalogue NumberHT087080
Device Lot Number6431947PP008
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/21/2020
Was the Report Sent to FDA? No
Initial Date Manufacturer Received Not provided
Initial Date FDA Received01/14/2020
Supplement Dates Manufacturer ReceivedNot provided
Not provided
Not provided
Not provided
Supplement Dates FDA Received03/10/2020
03/17/2020
03/31/2020
03/31/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Other; Required Intervention;
Patient Age32 YR
Patient Weight87
-
-